Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications

被引:28
作者
Falagas, M. E.
Mourtzoukou, E. G.
Polemis, M.
Vatopoulos, A. C.
机构
[1] Alfa Inst Biomed Sci, Maroussi 15123, Greece
[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[3] Natl Sch Publ Hlth, Dept Microbiol, Athens, Greece
关键词
Acinetobacter baumannii; antimicrobial resistance; Greek hospitals; imipenem; resistance; surveillance;
D O I
10.1111/j.1469-0691.2007.01761.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study analysed the proportions of Acinetobacter baumannii isolates resistant to various antibiotics that were recovered from patients hospitalised in Greek hospitals between 1996 and 2006. The microbiological data were derived from the ongoing WHONET Greek System for the Surveillance of Antibiotic Resistance. There were increases in the proportions of A. baumannii isolates resistant to imipenem from patients hospitalised in intensive care units, medical wards and surgical wards during the study period from 0% to 91%, 8% to 71%, and 5% to 71%, respectively.
引用
收藏
页码:816 / 819
页数:4
相关论文
共 21 条
  • [11] Evaluation of antimicrobial activity of β-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004)
    Ishii, Yoshikazu
    Alba, Jimena
    Kimura, Soichiro
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 55 (02) : 143 - 148
  • [12] Molecular investigation of an outbreak of multidrug-resistant Acinetobacter baumannii, with characterisation of class 1 integrons
    Kraniotaki, Eleni
    Manganelli, Riccardo
    Platsouka, Evangelia
    Grossato, Anna
    Paniara, Olga
    Palu, Giorgio
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (03) : 193 - 199
  • [13] Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong kong
    Ling, TKW
    Ying, CM
    Lee, CC
    Liu, ZK
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2005, 14 (05) : 338 - 341
  • [14] VEB-1 extended-spectrum β-lactamase-producing Acinetobacter baumannii, France
    Naas, Thierry
    Coignard, Bruno
    Carbonne, Anne
    Blanckaert, Karine
    Bajolet, Odile
    Bernet, Claude
    Verdeil, Xavier
    Astagneau, Pascal
    Desenclos, Jean-Claude
    Nordmann, Patrice
    [J]. EMERGING INFECTIOUS DISEASES, 2006, 12 (08) : 1214 - 1222
  • [15] Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit
    Pournaras, S
    Markogiannakis, A
    Ikonomidis, A
    Kondyli, L
    Bethimouti, K
    Maniatis, AN
    Legakis, NJ
    Tsakris, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (03) : 557 - 561
  • [16] Prashanth K, 2006, Indian J Med Microbiol, V24, P39
  • [17] Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)
    Rhomberg, PR
    Fritsche, TR
    Sader, HS
    Jones, RN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (04) : 249 - 257
  • [18] Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa
    Rice, Louis B.
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 : S100 - S105
  • [19] Tigecycline: First of a new class of antimicrobial agents
    Rose, Warren E.
    Rybak, Michael J.
    [J]. PHARMACOTHERAPY, 2006, 26 (08): : 1099 - 1110
  • [20] Tigecycline: a new glycylcycline antimicrobial
    Townsend, M. L.
    Pound, M. W.
    Drew, R. H.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (12) : 1662 - 1672